The financial landscape of 2026 is defined by a paradox: machine learning systems are now more powerful and autonomous than ever, yet they operate under the strictest regulatory scrutiny in history.

Ligand-based drug design combines AI and QSAR modeling to prioritize drug candidates, minimizing preclinical failures and ...

The landscape for video training data and multimodal foundation models in 2026 is defined by a shift from quantity to highly ...